Patents Assigned to PrimeCyte, Inc.
  • Methods for anti-tumor therapy
    Patent number: 6380167
    Abstract: The present invention provides novel methods, pharmaceutical compositions, and articles of manufacture for treating tumors that involve administering an effective amount of digitoxin, or a pharmaceutical salt thereof, wherein the tumor is selected from the group consisting of mesotheliomas, sarcomas, carcinomas, stromal cell, and germ cell tumors.
    Type: Grant
    Filed: February 10, 2000
    Date of Patent: April 30, 2002
    Assignee: PrimeCyte, Inc.
    Inventor: Irwin Braude